Questions Before Buying AI Compliance Tools

Questions pharma SMEs should ask before buying AI start with data, disposition, and auditability - not model brand names. Pharmaceutical and chemical SMEs are rightly cautious. Validation expectations, data integrity, and safety raise the bar. The wrong purchase creates shadow IT; the right one reduces repetitive documentation load under controlled conditions.

FDA's data integrity Q&A is a useful reminder: records must remain attributable and reconstructible even when assistants help.

What questions expose real product fit?

Ask vendors:

1. Which workflow is in scope on day one - and which decisions stay human-only?
2. How are sources cited, and can reviewers open the exact chunk?
3. How do you enforce access control on confidential dossiers?
4. What audit trail fields exist (who, when, model/policy version, override)?
5. How do you prevent external sends without approval?
6. What happens on ambiguous or low-confidence outputs?
7. Can we export case history for inspection without vendor login theater?

If answers are vague, walk. Related boundaries are covered in when not to automate compliance judgment.

What demos should you refuse?

• Auto-approve classification or market claims
• Chat over mixed personal drives with no ACL story
• "We fine-tune on your data" without a retention and deletion policy
• Accuracy claims with no operational metric plan

Demand a pilot charter instead - see pilot playbook choosing the first workflow and four-week compliance automation pilot.

What internal readiness questions come first?

Before procurement:

• Do we have case intake, or only email? - from inbox chaos to structured compliance review
• Who owns disposition for each case type?
• Which data may leave the tenant?
• How will we train reviewers? - preparing compliance teams for AI copilots
• How will we measure ROI? - measuring ROI of compliance automation

Buying software cannot invent an operating model.

How should security and quality teams score vendors?

Score 1-5 on:

• Citation quality
• ACL / tenancy story
• Audit-trail completeness
• Override UX
• Exportability
• Clarity of human-only boundaries
• Pilot instrumentation support

Weight ACL and disposition boundaries higher than chat polish in the scorecard. A pretty UI that cannot prove who approved what is a liability.

What contract clauses matter?

• Data residency and subprocessors
• Training-use prohibition on your content (unless explicitly agreed)
• Right to export and delete
• Incident notification
• Model/provider change notice
• Support for audit evidence packs

Have quality and IT review before commercial signature, not after the kickoff deck.

How should a small buyer team run vendor bake-offs?

Invite two vendors maximum. Give each the same three redacted cases and the same success rubric. Ban slide-only sessions; require a live run on your cases. Score independently, then compare. Include a quality person and an IT person in every session. Ask each vendor to fail gracefully: remove a document and show what the product does. Products that hallucinate confidently fail the bake-off regardless of UI polish. Budget time for security questionnaire follow-ups before commercial negotiation. If a vendor cannot complete your DPA questions in a week, treat that as a signal. Document why the loser lost so the next cycle does not restart from zero. Keep recordings and score sheets in a controlled folder. After selection, freeze scope to the pilot charter for 30 days - no "while we're here" modules. Scope creep during pilot week one destroys learning.

Checklist before you call the work done

Confirm owners, due dates, and evidence links on every open case. Confirm language packs and label stock match the controlled SDS revision. Confirm assistants cannot close regulated steps alone. Confirm metrics for the week are visible to quality leadership. If any box is unchecked, the process is not ready for more automation spend. Fix the box, then expand. That sequence protects trust with auditors, customers, and your own specialists who have seen tools come and go.

FAQ

Do we need CSV validation before any AI pilot?

Not always for assisted drafting with human approval - but you do need documented intended use, risk assessment, and controls proportionate to impact. Ask your QA lead early.

Should we prefer "life sciences only" vendors?

Domain focus helps, but evaluate evidence: citations, ACL, and disposition controls beat marketing vertical claims.

What is the one question that kills most bad demos?

"Show this workflow on our documents, with our acceptance criteria, and leave the audit trail on." If the vendor cannot, stop.